Treatment outcomes of patients treated with venetoclax-obinutuzumab therapy vs BTKi therapies in 1L CLL: An international real-world study Meeting Abstract
| Authors: | Lamanna, N.; Brown, J. R.; Ujjani, C. S.; Eyre, T. A.; Manzoor, B.; Ghosh, N.; Roeker, L.; Davids, M. S.; Coombs, C. C.; Skarbnik, A. P.; Hill, B. T.; Tuncer, H. H.; Leslie, L. A.; Rhodes, J. M.; Fleury, I.; Barr, P. M.; Emechebe, N.; Martinez-Calle, N.; Jensen, C. E.; Choi, Y.; Jawaid, D.; Pearson, L. K.; Thompson, M. C.; Marx, S. E.; Sinai, W. J.; Lansigan, F.; Fakhri, B.; Stephens, D. M.; Schuster, S. J.; Coyle, M.; Pivneva, I.; Watson, T.; Guerin, A.; Shadman, M. |
| Abstract Title: | Treatment outcomes of patients treated with venetoclax-obinutuzumab therapy vs BTKi therapies in 1L CLL: An international real-world study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 4625 |
| End Page: | 4628 |
| Language: | English |
| ACCESSION: | WOS:001416841400025 |
| DOI: | 10.1182/blood-2024-205223 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work